Search research articles
Contact Us
Filters
Showing results (11-20 of 215) with videos related to
Page
of 22
Sort By:
Seminars in Neurology
|
February 8, 2008
Recent advances in neuroimaging of multiple sclerosis
Waqar Rashid, David H Miller
Ecotoxicology and Environmental Safety
|
July 21, 2004
Modeling impacts on populations: fathead minnow (Pimephales promelas) exposure to the endocrine disruptor 17beta-trenbolone as a case study
David H Miller, Gerald T Ankley
The Lancet. Neurology
|
September 22, 2007
Primary-progressive multiple sclerosis
David H Miller, Siobhan M Leary
Brain : a Journal of Neurology
|
January 10, 2016
What lies beneath grey matter atrophy in multiple sclerosis?
Declan T Chard, David H Miller
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 17, 2014
Clinically isolated syndromes and the relationship to multiple sclerosis
Wallace J Brownlee, David H Miller
The Lancet. Neurology
|
June 20, 2014
Baló's concentric sclerosis
Todd A Hardy, David H Miller
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 19, 2017
Advancing trial design in progressive multiple sclerosis
David H Miller, Alan J Thompson
Neurology
|
August 21, 2009
What you see depends on how you look: Gray matter lesions in multiple sclerosis
Declan T Chard, David H Miller
Lancet (London, England)
|
October 10, 2009
Treatment of clinically isolated syndrome: to be PreCISe
David H Miller, Siobhan M Leary
Neurology
|
January 10, 2002
Infections and MS: clinical trials move to center stage
Andrew D Goodman, David H Miller
Page
of 22
Search research articles
Search
Showing results (11-20 of 215) with videos related to
Sort By:
Page
of 22
Seminars in Neurology
|
February 8, 2008
Recent advances in neuroimaging of multiple sclerosis
Waqar Rashid, David H Miller
Ecotoxicology and Environmental Safety
|
July 21, 2004
Modeling impacts on populations: fathead minnow (Pimephales promelas) exposure to the endocrine disruptor 17beta-trenbolone as a case study
David H Miller, Gerald T Ankley
The Lancet. Neurology
|
September 22, 2007
Primary-progressive multiple sclerosis
David H Miller, Siobhan M Leary
Brain : a Journal of Neurology
|
January 10, 2016
What lies beneath grey matter atrophy in multiple sclerosis?
Declan T Chard, David H Miller
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 17, 2014
Clinically isolated syndromes and the relationship to multiple sclerosis
Wallace J Brownlee, David H Miller
The Lancet. Neurology
|
June 20, 2014
Baló's concentric sclerosis
Todd A Hardy, David H Miller
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 19, 2017
Advancing trial design in progressive multiple sclerosis
David H Miller, Alan J Thompson
Neurology
|
August 21, 2009
What you see depends on how you look: Gray matter lesions in multiple sclerosis
Declan T Chard, David H Miller
Lancet (London, England)
|
October 10, 2009
Treatment of clinically isolated syndrome: to be PreCISe
David H Miller, Siobhan M Leary
Neurology
|
January 10, 2002
Infections and MS: clinical trials move to center stage
Andrew D Goodman, David H Miller
Page
of 22